Molekulare Marker in Diagnostik und Therapie des Urothelkarzinoms
Explore this paper's citation graph
Summary
No single marker gives a clear Yes-or-no prognostic answer but always only a measure of probability, the use of marker systems has so far not gained widespread clinical applications and this will likely change in future.
- Type
- article
- Published
- 2010-10-21
- Cited by
- 6
- References
- 67
- OpenAlex
- https://openalex.org/W16257296
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8269628
Keywords
Gynecology, Medicine
References
- Prognostic significance of survivin‐expressing circulating tumour cells in T1G3 bladder cancer
- Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
- Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
- Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy
- Serum CYFRA 21-1 in patients with invasive bladder cancer and its relevance as a tumor marker during chemotherapy.
- Utility of Diagnostic and Prognostic Markers in Urothelial Carcinoma of the Bladder
- Clusterin as a Diagnostic and Prognostic Marker for Transitional Cell Carcinoma of the Bladder
- Detection of circulating tumor cells in bladder cancer patients.
- Prognostic significance of p27Kip1 expression in bladder cancer
- Long‐term outcome of hematuria home screening for bladder cancer in men
- Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
- PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors.
- Expression of transitional cell‐specific genes, uroplakin Ia and II, in bladder cancer: Detection of circulating cancer cells in the peripheral blood of metastatic patients
- Bladder cancer biomarkers: current developments and future implementation
- The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.
- Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.
- Emerging apoptosis agonists for bladder cancer
- Discriminatory Immunohistochemical Staining of Urothelial Carcinoma in Situ and Non-neoplastic Urothelium: An Analysis of Cytokeratin 20, p53, and CD44 Antigens
- Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States.
- Detection of tumours of the urinary tract in voided urine
Cited by
- Vorkommen einer p16INK4a-Expression in Zytologien der Harnblase
- Die Wertigkeit des UBC-Point-of-Care Tests in der Diagnostik des Urothelkarzinoms - Untersuchung einer repräsentativen Standardpopulation
- Nutzung von Markersystemen in der Behandlung des Harnblasenkarzinoms
- Urinary immunocytology--promise or nonseller? A review with an opinion.
- Urinzytologie – Update 2013
- Modern methods of diagnostics and prediction of urothelial cancer of the urinary bladder
Related papers
- Genentech taps Affimed’s antibodies
- KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria
- Cardiac retransplantation in children.
- Avaliacao hemodinamica sequencial em transplante de coracao
- Thoracoscopic discectomy and fusion in the treatment of spinal deformities
- [Hepatic retransplant and acute Budd Chiari syndrome. Case report].
- Caudal Anaesthesia with Levobupivacaine for Inguinal Hernia Surgery in Children with Severe Congenital Anomaly: A Three-Case Report